Skip to main content
Top
Published in: Digestive Diseases and Sciences 4/2018

01-04-2018 | Original Article

An Analysis of the Clinical, Laboratory, and Histological Features of Striped, Punctate, and Nodular Gastric Antral Vascular Ectasia

Authors: Arul Thomas, David Koch, William Marsteller, David Lewin, Adrian Reuben

Published in: Digestive Diseases and Sciences | Issue 4/2018

Login to get access

Abstract

Background

Gastric antral vascular ectasia (GAVE) commonly presents as linear striped (“watermelon stomach”) or punctate phenotypes, to which a newly discovered nodular form was recently added.

Aims

We performed a retrospective cohort study to detail and compare the clinical and histological characteristics of major GAVE phenotypes.

Methods

In 136 GAVE patients (tertiary care ambulatory and inpatient, median age 61.3 years, 73 men, and 63 women), clinical and laboratory results were recorded, with comorbidities, endoscopy indications, and complications of cirrhosis. In 74 patients, GAVE histopathology was cataloged by a pathologist masked to endoscopy results.

Results

Median age 61.3 years, 73 men, and 63 women. GAVE phenotypes were: linear striped—62 (46%), punctate—32 (24%), and nodular—41 (30%). Endoscopy was commonly performed for variceal screening in linear striped (45%) and nodular (34%) GAVE and for gastrointestinal bleeding in punctate (41%) and nodular (29%) GAVE, respectively. Of 89 cirrhotic patients, 37.5% each had linear striped or nodular GAVE, 24.7% had punctate forms (p = 0.03). Child–Turcotte–Pugh and Model for End-Stage Liver Disease scores were similar among phenotypes. Histologically, reactive epithelial hyperplasia and vascular ectasia were universal; smooth muscle proliferation was more common and consistent (78–86%) than microvascular thrombi (27–59%) and fibrohyalinosis (18–53%), which each varied with phenotype.

Conclusions

Nodular GAVE is a gastric mucosal abnormality that is similar to the linear striped and punctate phenotypes, yet has distinct clinical and histological features. Increased awareness of nodular GAVE by endoscopists is needed to avoid its misdiagnosis as nonspecific antral nodules.
Literature
1.
go back to reference Jabbari M, Cherry R, Lough JO, et al. Gastric antral vascular ectasia: the watermelon stomach. Gastroenterology. 1984;87:1165–1170.PubMed Jabbari M, Cherry R, Lough JO, et al. Gastric antral vascular ectasia: the watermelon stomach. Gastroenterology. 1984;87:1165–1170.PubMed
2.
go back to reference Ripoll C, Garcia-Tsao G. The management of portal hypertensive gastropathy and gastric antral vascular ectasia. Dig Liver Dis. 2011;43:345–351.CrossRefPubMed Ripoll C, Garcia-Tsao G. The management of portal hypertensive gastropathy and gastric antral vascular ectasia. Dig Liver Dis. 2011;43:345–351.CrossRefPubMed
3.
go back to reference Ito M, Uchida Y, Kamano S, et al. Clinical comparisons between two subsets of gastric antral vascular ectasia. Gastrointest Endosc. 2001;53:764–770.CrossRefPubMed Ito M, Uchida Y, Kamano S, et al. Clinical comparisons between two subsets of gastric antral vascular ectasia. Gastrointest Endosc. 2001;53:764–770.CrossRefPubMed
4.
go back to reference Spahr L, Villeneuve JP, Dufresne MP, et al. Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut. 1999;44:739–742.CrossRefPubMedPubMedCentral Spahr L, Villeneuve JP, Dufresne MP, et al. Gastric antral vascular ectasia in cirrhotic patients: absence of relation with portal hypertension. Gut. 1999;44:739–742.CrossRefPubMedPubMedCentral
5.
go back to reference Kamath PS, Lacerda M, Ahlquist DA, et al. Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology. 2000;118:905–911.CrossRefPubMed Kamath PS, Lacerda M, Ahlquist DA, et al. Gastric mucosal responses to intrahepatic portosystemic shunting in patients with cirrhosis. Gastroenterology. 2000;118:905–911.CrossRefPubMed
6.
go back to reference Quintero E, Pigue JM, Bombi JA, et al. Gastric mucosal ectasias causing bleeding in cirrhosis. A distinct entity associated with hypergastrinemia and low serum levels of pepsinogen I. Gastroenterology. 1987;93:1054–1061.CrossRefPubMed Quintero E, Pigue JM, Bombi JA, et al. Gastric mucosal ectasias causing bleeding in cirrhosis. A distinct entity associated with hypergastrinemia and low serum levels of pepsinogen I. Gastroenterology. 1987;93:1054–1061.CrossRefPubMed
7.
go back to reference Marsteller WF, Lewin DN, Reuben A. The biopsy GAVE the diagnosis. Clin Gastroenterol Hepatol. 2012;10:e75–e76.CrossRefPubMed Marsteller WF, Lewin DN, Reuben A. The biopsy GAVE the diagnosis. Clin Gastroenterol Hepatol. 2012;10:e75–e76.CrossRefPubMed
8.
go back to reference Tyagi P, Puri AS, Sharma BC, et al. Nodules in antrum after variceal eradication a new finding in patients with portal hypertension. Indian J Gastroenterol. 2012;31:75–78.CrossRefPubMed Tyagi P, Puri AS, Sharma BC, et al. Nodules in antrum after variceal eradication a new finding in patients with portal hypertension. Indian J Gastroenterol. 2012;31:75–78.CrossRefPubMed
9.
go back to reference Stewart CA, Sanyal AJ. Grading portal gastropathy: validation of a portal gastropathy scoring system. Am J Gastroenterol. 2003;98:1758–1765.CrossRefPubMed Stewart CA, Sanyal AJ. Grading portal gastropathy: validation of a portal gastropathy scoring system. Am J Gastroenterol. 2003;98:1758–1765.CrossRefPubMed
10.
go back to reference Chawla SK, Ramani K, Lo Presti P. The honeycomb stomach: coalesced gastric angiodysplasia. Gastrointest Endosc. 1990;36:516–518.CrossRefPubMed Chawla SK, Ramani K, Lo Presti P. The honeycomb stomach: coalesced gastric angiodysplasia. Gastrointest Endosc. 1990;36:516–518.CrossRefPubMed
11.
go back to reference Suit PF, Petras RE, Bauer TW, et al. Gastric antral vascular ectasia. A histologic and morphometric study of “the watermelon stomach”. Am J Surg Pathol. 1987;11:750–757.CrossRefPubMed Suit PF, Petras RE, Bauer TW, et al. Gastric antral vascular ectasia. A histologic and morphometric study of “the watermelon stomach”. Am J Surg Pathol. 1987;11:750–757.CrossRefPubMed
12.
go back to reference Payen JL, Cales P, Voigt JJ, et al. Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis. Gastroenterology. 1995;108:138–144.CrossRefPubMed Payen JL, Cales P, Voigt JJ, et al. Severe portal hypertensive gastropathy and antral vascular ectasia are distinct entities in patients with cirrhosis. Gastroenterology. 1995;108:138–144.CrossRefPubMed
13.
go back to reference Lucey MR, Brown KA, Everson GT, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Transplantation. 1998;66:956–962.CrossRefPubMed Lucey MR, Brown KA, Everson GT, et al. Minimal criteria for placement of adults on the liver transplant waiting list: a report of a national conference organized by the American Society of Transplant Physicians and the American Association for the Study of Liver Diseases. Transplantation. 1998;66:956–962.CrossRefPubMed
14.
go back to reference Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–470.CrossRefPubMed Kamath PS, Wiesner RH, Malinchoc M, et al. A model to predict survival in patients with end-stage liver disease. Hepatology. 2001;33:464–470.CrossRefPubMed
15.
go back to reference Abraham SC, Singh VK, Yardley JH, et al. Hyperplastic polyps of the stomach: associations with histologic patterns of gastritis and gastric atrophy. Am J Surg Pathol. 2001;25:500–507.CrossRefPubMed Abraham SC, Singh VK, Yardley JH, et al. Hyperplastic polyps of the stomach: associations with histologic patterns of gastritis and gastric atrophy. Am J Surg Pathol. 2001;25:500–507.CrossRefPubMed
16.
go back to reference Baudet JS, Salata H, Soler M, et al. Hyperplastic gastric polyps after argon plasma coagulation treatment of gastric antral vascular ectasia (GAVE). Endoscopy. 2007;39:E320.CrossRefPubMed Baudet JS, Salata H, Soler M, et al. Hyperplastic gastric polyps after argon plasma coagulation treatment of gastric antral vascular ectasia (GAVE). Endoscopy. 2007;39:E320.CrossRefPubMed
17.
go back to reference Kotzampassi K, Eleftheriadis E, Aletras H. The ‘mosaic like’ pattern of portal hypertensive gastric mucosa after variceal eradication by sclerotherapy. J Gastroenterol Hepatol. 1990;5:659–663.CrossRefPubMed Kotzampassi K, Eleftheriadis E, Aletras H. The ‘mosaic like’ pattern of portal hypertensive gastric mucosa after variceal eradication by sclerotherapy. J Gastroenterol Hepatol. 1990;5:659–663.CrossRefPubMed
18.
go back to reference Gostout CJ, Viggiano TR, Ahlquist DA, et al. The clinical and endoscopic spectrum of the watermelon stomach. J Clin Gastroenterol. 1992;15:256–263.CrossRefPubMed Gostout CJ, Viggiano TR, Ahlquist DA, et al. The clinical and endoscopic spectrum of the watermelon stomach. J Clin Gastroenterol. 1992;15:256–263.CrossRefPubMed
Metadata
Title
An Analysis of the Clinical, Laboratory, and Histological Features of Striped, Punctate, and Nodular Gastric Antral Vascular Ectasia
Authors
Arul Thomas
David Koch
William Marsteller
David Lewin
Adrian Reuben
Publication date
01-04-2018
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 4/2018
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-4965-z

Other articles of this Issue 4/2018

Digestive Diseases and Sciences 4/2018 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.